FDA.reportPublic FDA data

pyridostigmine bromide 105 MG (equivalent to pyridostigmine 72.87 MG) 24 HR Extended Release Oral Tablet

RxCUI
2695047
RxNorm name
pyridostigmine bromide 105 MG (equivalent to pyridostigmine 72.87 MG) 24 HR Extended Release Oral Tablet
Display name
pyridostigmine bromide 105 MG (equivalent to pyridostigmine 72.87 MG) 24 HR Extended Release Oral Tablet
Full name
pyridostigmine bromide 105 MG (equivalent to pyridostigmine 72.87 MG) 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pyridostigmine bromidePYRIDOSTIGMINE BROMIDEAmneal Pharmaceuticals LLC52d6f195-165a-400b-a13b-489e94bcf0b02026-05-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2695047

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
52d6f195-165a-400b-a13b-489e94bcf0b0pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR pyridostigmine bromide 105 MG Extended Release Oral Tablet [SCD] · pyridostigmine bromide 105 MG (equivalent to pyridostigmine 72.87 MG) 24 HR Extended Release Oral Tablet [SY] · pyridostigmine bromide 105 MG 24 HR Extended Release Oral Tablet [SY]48These highlights do not include all the information needed to use PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS. PYRIDOSTIGMINE BROMIDE extended-release tablets, for oral use Initial U.S. Approval: 195520260513